Intrapatient Variations in Type 1 Diabetes-specific iPS Cell Differentiation into Insulin-producing Cells

Molecular Therapy

Volumn 21, Issue 1, 2013, Pages 228-239

  Thatava, Tayaramma ^a   Kudva, Yogish C ^a   Edukulla, Ramakrishna ^a   Squillace, Karen ^a   De Lamo, Josep Genebriera ^a   Khan, Yulia Krotova ^a   Sakuma, Toshie ^a   Ohmine, Seiga ^a   Terzic, Andre ^a,b,c   Ikeda, Yasuhiro ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INSULIN; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2;

ADOLESCENT; ADULT; ARTICLE; CELL ASSAY; CELL CLONE; CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL PROTOCOL; CLONAL VARIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MALE; PANCREAS CELL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SCREENING TEST; UPREGULATION;

IPS;

EID: 84871869282     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.245     Document Type: Article

References (50)

1. Takahashi, K, Tanabe, K, Ohnuki, M, Narita, M, Ichisaka, T, Tomoda, K et al. (2007).Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell 131: 861-872. (Pubitemid 350138099)
2. Yu, J, Vodyanik, MA, Smuga-Otto, K, Antosiewicz-Bourget, J, Frane, JL, Tian, S et al.(2007). Induced pluripotent stem cell lines derived from human somatic cells. Science318: 1917-1920.
3. Park, IH, Zhao, R, West, JA, Yabuuchi, A, Huo, H, Ince, TA et al. (2008).Reprogramming of human somatic cells to pluripotency with defined factors. Nature451: 141-146.
4. Giorgetti, A, Montserrat, N, Aasen, T, Gonzalez, F, Rodruez-Piz I, Vassena, R et al.(2009). Generation of induced pluripotent stem cells from human cord blood usingOCT4 and SOX2. Cell Stem Cell 5: 353-357.
5. Loh, YH, Agarwal, S, Park, IH, Urbach, A, Huo, H, Heffner, GC et al. (2009).Generation of induced pluripotent stem cells from human blood. Blood 113:5476-5479.
6. Stadtfeld, M, Brennand, K and Hochedlinger, K (2008). Reprogramming of pancreaticbeta cells into induced pluripotent stem cells. Curr Biol 18: 890-894.
7. Lowry, WE, Richter, L, Yachechko, R, Pyle, AD, Tchieu, J, Sridharan, R et al. (2008).Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc NatlAcad Sci USA 105: 2883-2888. (Pubitemid 351723638)
8. Aasen, T, Raya, A, Barrero, MJ, Garreta, E, Consiglio, A, Gonzalez, F et al. (2008).Efficient and rapid generation of induced pluripotent stem cells from humankeratinocytes. Nat Biotechnol 26: 1276-1284.
9. Agarwal, S, Loh, YH, McLoughlin, EM, Huang, J, Park, IH, Miller, JD et al. (2010).Telomere elongation in induced pluripotent stem cells from dyskeratosis congenitapatients. Nature 464: 292-296.
10. Dimos, JT, Rodolfa, KT, Niakan, KK, Weisenthal, LM, Mitsumoto, H, Chung, W etal. (2008). Induced pluripotent stem cells generated from patients with ALS can bedifferentiated into motor neurons. Science 321: 1218-1221.
11. Park, IH, Arora, N, Huo, H, Maherali, N, Ahfeldt, T, Shimamura, A et al. (2008).Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
12. Raya, A, Rodruez-Piz I, Guenechea, G, Vassena, R, Navarro, S, Barrero, MJ et al.(2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia inducedpluripotent stem cells. Nature 460: 53-59.
13. Howden, SE, Gore, A, Li, Z, Fung, HL, Nisler, BS, Nie, J et al. (2011). Geneticcorrection and analysis of induced pluripotent stem cells from a patient with gyrateatrophy. Proc Natl Acad Sci USA 108: 6537-6542.
14. Ebert, AD, Yu, J, Rose, FF Jr, Mattis, VB, Lorson, CL, Thomson, JA et al. (2009).Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
15. Lee, TH, Song, SH, Kim, KL, Yi, JY, Shin, GH, Kim, JY et al. (2010). Functionalrecapitulation of smooth muscle cells via induced pluripotent stem cells from humanaortic smooth muscle cells. Circ Res 106: 120-128.
16. Carvajal-Vergara, X, Sevilla, A, D'Souza, SL, Ang, YS, Schaniel, C, Lee, DF et al. (2010).Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome.Nature 465: 808-812.
17. Ounissi-Benkalha, H and Polychronakos, C (2008). The molecular genetics of type 1diabetes: new genes and emerging mechanisms. Trends Mol Med 14: 268-275.
18. Yokoi, N, Hayashi, C, Fujiwara, Y, Wang, HY and Seino, S (2007). Geneticreconstitution of autoimmune type 1 diabetes with two major susceptibility genes inthe rat. Diabetes 56: 506-512.
19. Brons, IG, Smithers, LE, Trotter, MW, Rugg-Gunn, P, Sun, B, Chuva de Sousa Lopes,SM et al. (2007). Derivation of pluripotent epiblast stem cells from mammalianembryos. Nature 448: 191-195. (Pubitemid 47067373)
20. Bach, JF and Mathis, D (1997). The NOD mouse. Res Immunol 148: 285-286. (Pubitemid 27435910)
21. Hanna, J, Markoulaki, S, Mitalipova, M, Cheng, AW, Cassady, JP, Staerk, J et al.(2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4:513-524.
22. D'Amour, KA, Bang, AG, Eliazer, S, Kelly, OG, Agulnick, AD, Smart, NG et al. (2006).Production of pancreatic hormone-expressing endocrine cells from human embryonicstem cells. Nat Biotechnol 24: 1392-1401. (Pubitemid 44722103)
23. Kroon, E, Martinson, LA, Kadoya, K, Bang, AG, Kelly, OG, Eliazer, S et al. (2008).Pancreatic endoderm derived from human embryonic stem cells generates glucoseresponsiveinsulin-secreting cells in vivo. Nat Biotechnol 26: 443-452. (Pubitemid 351501814)
24. Jiang, J, Au, M, Lu, K, Eshpeter, A, Korbutt, G, Fisk, G et al. (2007). Generation ofinsulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25:1940-1953. (Pubitemid 47258172)
25. Jiang, W, Shi, Y, Zhao, D, Chen, S, Yong, J, Zhang, J et al. (2007). In vitro derivationof functional insulin-producing cells from human embryonic stem cells. Cell Res 17:333-344. (Pubitemid 46639938)
26. Zhang, D, Jiang, W, Liu, M, Sui, X, Yin, X, Chen, S et al. (2009). Highly efficientdifferentiation of human ES cells and iPS cells into mature pancreatic insulinproducingcells. Cell Res 19: 429-438.
27. Tateishi, K, He, J, Taranova, O, Liang, G, D'Alessio, AC and Zhang, Y (2008).Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J BiolChem 283: 31601-31607.
28. Thatava, T, Nelson, TJ, Edukulla, R, Sakuma, T, Ohmine, S, Tonne, JM et al. (2011).Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucoseresponsiveinsulin-secreting progeny. Gene Ther 18: 283-293.
29. Nostro, MC, Sarangi, F, Ogawa, S, Holtzinger, A, Corneo, B, Li, X et al. (2011).Stage-specific signaling through TGF? family members and WNT regulatespatterning and pancreatic specification of human pluripotent stem cells.Development 138: 861-871.
30. Maehr, R, Chen, S, Snitow, M, Ludwig, T, Yagasaki, L, Goland, R et al. (2009).Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl AcadSci USA 106: 15768-15773.
31. Taapken, SM, Nisler, BS, Newton, MA, Sampsell-Barron, TL, Leonhard, KA, McIntire,EM et al. (2011). Karotypic abnormalities in human induced pluripotent stem cellsand embryonic stem cells. Nat Biotechnol 29: 313-314.
32. Kudva, YC, Ohmine, S, Greder, LV, Dutton, JR, Armstrong, A, De Lamo, JG et al.(2012). Transgene-free disease-specific induced pluripotent stem cells from patientswith type 1 and type 2 diabetes. Stem Cells Trans Med 1: 451-461.
33. Soldner, F, Lagani?e, J, Cheng, AW, Hockemeyer, D, Gao, Q, Alagappan, R et al.(2011). Generation of isogenic pluripotent stem cells differing exclusively at two earlyonset Parkinson point mutations. Cell 146: 318-331.
34. Hussein, SM, Batada, NN, Vuoristo, S, Ching, RW, Autio, R, Nv E et al. (2011).Copy number variation and selection during reprogramming to pluripotency. Nature471: 58-62.
35. Gore, A, Li, Z, Fung, HL, Young, JE, Agarwal, S, Antosiewicz-Bourget, J et al. (2011).Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-67.
36. Lister, R, Pelizzola, M, Kida, YS, Hawkins, RD, Nery, JR, Hon, G et al. (2011). Hotspotsof aberrant epigenomic reprogramming in human induced pluripotent stem cells.Nature 471: 68-73.
37. Mayshar, Y, Ben-David, U, Lavon, N, Biancotti, JC, Yakir, B, Clark, AT et al. (2010).Identification and classification of chromosomal aberrations in human inducedpluripotent stem cells. Cell Stem Cell 7: 521-531.
38. Zhao, T, Zhang, ZN, Rong, Z and Xu, Y (2011). Immunogenicity of inducedpluripotent stem cells. Nature 474: 212-215.
39. Osafune, K, Caron, L, Borowiak, M, Martinez, RJ, Fitz-Gerald, CS, Sato, Y et al. (2008).Marked differences in differentiation propensity among human embryonic stem celllines. Nat Biotechnol 26: 313-315. (Pubitemid 351355125)
40. Bock, C, Kiskinis, E, Verstappen, G, Gu, H, Boulting, G, Smith, ZD et al. (2011).Reference Maps of human ES and iPS cell variation enable high-throughputcharacterization of pluripotent cell lines. Cell 144: 439-452.
41. Polo, JM, Liu, S, Figueroa, ME, Kulalert, W, Eminli, S, Tan, KY et al. (2010). Celltype of origin influences the molecular and functional properties of mouse inducedpluripotent stem cells. Nat Biotechnol 28: 848-855.
42. Hotta, A and Ellis, J (2008). Retroviral vector silencing during iPS cell induction:an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem 105:940-948.
43. Kim, K, Zhao, R, Doi, A, Ng, K, Unternaehrer, J, Cahan, P et al. (2011). Donor celltype can influence the epigenome and differentiation potential of human inducedpluripotent stem cells. Nat Biotechnol 29: 1117-1119.
44. Cherry, AB and Daley, GQ (2012). Reprogramming cellular identity for regenerativemedicine. Cell 148: 1110-1122.
45. Yu, J, Hu, K, Smuga-Otto, K, Tian, S, Stewart, R, Slukvin, II et al. (2009). Human inducedpluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
46. VandenDriessche, T, Ivics, Z, Izsv, Z and Chuah, MK (2009). Emerging potential oftransposons for gene therapy and generation of induced pluripotent stem cells. Blood114: 1461-1468.
47. Seki, T, Yuasa, S, Oda, M, Egashira, T, Yae, K, Kusumoto, D et al. (2010). Generation ofinduced pluripotent stem cells from human terminally differentiated circulating T cells.Cell Stem Cell 7: 11-14.
48. Anokye-Danso, F, Trivedi, CM, Juhr, D, Gupta, M, Cui, Z, Tian, Y et al. (2011). Highlyefficient miRNA-mediated reprogramming of mouse and human somatic cells topluripotency. Cell Stem Cell 8: 376-388.
49. Thatava, T, Armstrong, AS, De Lamo, JG, Edukulla, R, Khan, YK, Sakuma, T et al.(2011). Successful disease-specific induced pluripotent stem cell generation frompatients with kidney transplantation. Stem Cell Res Ther 2: 48.
50. Nelson, TJ, Martinez-Fernandez, A, Yamada, S, Mael, AA, Terzic, A and Ikeda, Y(2009). Induced pluripotent reprogramming from promiscuous human stemnessrelated factors. Clin Transl Sci 2: 118-126.